Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R05 COUGH AND COLD PREPARATIONS
R05D COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS
R05DB Other cough suppressants
R05DB29 Gefapixant
D11693 Gefapixant citrate (JAN/USAN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
22 Respiratory organ agents
229 Miscellaneous
2290 Miscellaneous
D11693 Gefapixant citrate (JAN/USAN)
Drug groups [BR:br08330]
Unclassified
DG03292 Purinergic receptor P2X 3 antagonist
DG03083 Gefapixant
D11693 Gefapixant citrate
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
ATP-gated cation channel (P2X)
P2RX3
D11693 Gefapixant citrate (JAN/USAN) <JP>
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D11693
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D11693
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11693
Drug groups [BR:br08330]
Unclassified
DG03292 Purinergic receptor P2X 3 antagonist
DG03083 Gefapixant